Cui-Yun Liu

5.2k total citations · 3 hit papers
46 papers, 4.1k citations indexed

About

Cui-Yun Liu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Cui-Yun Liu has authored 46 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 25 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Cui-Yun Liu's work include MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (9 papers). Cui-Yun Liu is often cited by papers focused on MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (9 papers). Cui-Yun Liu collaborates with scholars based in China, United States and Australia. Cui-Yun Liu's co-authors include Lu‐Yu Zhou, Peifeng Li, Kun Wang, Fang Liu, Bo Long, Teng Sun, Man Wang, Yanhan Dong, Jianxun Wang and Murugavel Ponnusamy and has published in prestigious journals such as Circulation, Nature Communications and Circulation Research.

In The Last Decade

Cui-Yun Liu

43 papers receiving 4.0k citations

Hit Papers

A circular RNA protects the heart from pathological hyper... 2014 2026 2018 2022 2016 2014 2015 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cui-Yun Liu China 24 3.4k 2.9k 429 428 245 46 4.1k
Regalla Kumarswamy Germany 20 2.6k 0.8× 2.2k 0.8× 426 1.0× 131 0.3× 239 1.0× 23 3.5k
William W. Du Canada 38 6.3k 1.9× 5.4k 1.9× 152 0.4× 166 0.4× 258 1.1× 72 7.2k
Ingeborg van der Made Netherlands 27 1.9k 0.6× 1.1k 0.4× 658 1.5× 200 0.5× 340 1.4× 46 3.0k
Christian Bär Germany 28 1.7k 0.5× 1.1k 0.4× 461 1.1× 81 0.2× 172 0.7× 87 2.5k
Carmen C. Sucharov United States 30 1.6k 0.5× 543 0.2× 910 2.1× 228 0.5× 265 1.1× 96 2.6k
Yun Zhong China 25 1.2k 0.4× 540 0.2× 213 0.5× 559 1.3× 215 0.9× 66 2.3k
Ji Heon Noh South Korea 29 3.2k 0.9× 2.0k 0.7× 72 0.2× 311 0.7× 69 0.3× 55 3.9k

Countries citing papers authored by Cui-Yun Liu

Since Specialization
Citations

This map shows the geographic impact of Cui-Yun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui-Yun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui-Yun Liu more than expected).

Fields of papers citing papers by Cui-Yun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cui-Yun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui-Yun Liu. The network helps show where Cui-Yun Liu may publish in the future.

Co-authorship network of co-authors of Cui-Yun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Cui-Yun Liu. A scholar is included among the top collaborators of Cui-Yun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cui-Yun Liu. Cui-Yun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xing, Jing, Cui-Yun Liu, Yaqi Li, et al.. (2025). Dual advantages of SN38 prodrug nanoassemblies overcome defects of irinotecan and SN38: enhanced stability and activatability. Science China Chemistry. 68(11). 5960–5970. 1 indexed citations
2.
Wang, Tao, Xinzhe Chen, Hongfei Xu, et al.. (2025). MCPPIR promotes cardiomyocyte proliferation and cardiac repair via o8G oxidation of POC1B mRNA. Cardiovascular Research. 122(2). 270–284.
3.
Chen, Xinzhe, et al.. (2025). Regenerative therapies for myocardial infarction: exploring the critical role of energy metabolism in achieving cardiac repair. Frontiers in Cardiovascular Medicine. 12. 1533105–1533105. 1 indexed citations
4.
Wang, Danping, Qing Wang, Shiyi Zuo, et al.. (2024). Reductants supplement boost the antitumor efficacy of nanomedicine. Chemical Engineering Journal. 498. 155076–155076.
5.
Ju, Jie, Kai Wang, Fang Liu, et al.. (2024). Crotonylation of NAE1 Modulates Cardiac Hypertrophy via Gelsolin Neddylation. Circulation Research. 135(8). 806–821. 9 indexed citations
6.
Liu, Cui-Yun, Xinzhe Chen, Kai Wang, et al.. (2024). Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer. Journal of Translational Medicine. 22(1). 1137–1137. 10 indexed citations
7.
Wang, Tao, Xinzhe Chen, Jie Ju, et al.. (2023). Cardiac regeneration: Pre-existing cardiomyocyte as the hub of novel signaling pathway. Genes & Diseases. 11(2). 747–759. 8 indexed citations
8.
Wang, Fei, Cui-Yun Liu, Jing Li, et al.. (2022). Sensitive naked-eye detection of telomerase activity based on exponential amplification reaction and lateral flow assay. Analytical and Bioanalytical Chemistry. 414(20). 6139–6147. 4 indexed citations
9.
Wang, Hongtao, Jie Ju, Shaocong Wang, et al.. (2022). Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer. Frontiers in Oncology. 12. 812534–812534. 22 indexed citations
10.
Ju, Jie, Yanan Song, Xinzhe Chen, et al.. (2021). circRNA is a potential target for cardiovascular diseases treatment. Molecular and Cellular Biochemistry. 477(2). 417–430. 40 indexed citations
11.
Gao, Xiangqian, Cui-Yun Liu, Yuhui Zhang, et al.. (2021). The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression. Cell Death and Differentiation. 29(3). 527–539. 63 indexed citations
12.
Wang, Tao, Mei Zhai, Sheng Xu, et al.. (2019). NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression. Theranostics. 10(2). 553–566. 38 indexed citations
13.
Zhou, Lu‐Yu, Mei Zhai, Yan Huang, et al.. (2018). The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/ FAM65B pathway. Cell Death and Differentiation. 26(7). 1299–1315. 213 indexed citations
14.
Wang, Feng, Hui Deng, Cui-Yun Liu, et al.. (2015). Distributed Data-Processing Pipeline for Mingantu Ultrawide Spectral Radioheliograph. Publications of the Astronomical Society of the Pacific. 127(950). 383–396. 8 indexed citations
15.
Wang, Kun, Lu‐Yu Zhou, Jianxun Wang, et al.. (2015). E2F1-dependent miR-421 regulates mitochondrial fragmentation and myocardial infarction by targeting Pink1. Nature Communications. 6(1). 7619–7619. 88 indexed citations
16.
Wang, Kai, Bo Long, Tao An, et al.. (2015). NFAT4-dependent miR-324-5p regulates mitochondrial morphology and cardiomyocyte cell death by targeting Mtfr1. Cell Death and Disease. 6(12). e2007–e2007. 49 indexed citations
17.
Wang, Kai, Tao An, Lu‐Yu Zhou, et al.. (2014). E2F1-regulated miR-30b suppresses Cyclophilin D and protects heart from ischemia/reperfusion injury and necrotic cell death. Cell Death and Differentiation. 22(5). 743–754. 58 indexed citations
18.
Wang, Kun, Bo Long, Lu‐Yu Zhou, et al.. (2014). CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nature Communications. 5(1). 3596–3596. 394 indexed citations
19.
Long, Bo, Kun Wang, Na Li, et al.. (2013). miR-761 regulates the mitochondrial network by targeting mitochondrial fission factor. Free Radical Biology and Medicine. 65. 371–379. 89 indexed citations
20.
Wang, Kai, Fang Liu, Lu‐Yu Zhou, et al.. (2013). miR-874 regulates myocardial necrosis by targeting caspase-8. Cell Death and Disease. 4(7). e709–e709. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026